DNA damage checkpoint kinases in cancer

Area of Science:

• Molecular Biology
• Cell Biology
• Genetics

Background:

• The DNA damage response (DDR) pathway is a crucial network of signaling and repair pathways that prevents replication of DNA damage.
• Cell cycle checkpoints, including G1, S, and G2/M, are regulated by specific DDR pathways like ATM-CHK2-p53 and ATR-CHK1-Wee1.
• Loss of G1 checkpoint control, often due to TP53 or ATM mutations, is frequent in cancer, highlighting the importance of targeting S/G2 checkpoints.

Purpose of the Study:

• This review focuses on the ATM-CHK2-p53-p21 and ATR-CHK1-WEE1 pathways within the DDR network.
• It examines ongoing therapeutic strategies aimed at targeting these specific DDR pathways for patient benefit.

Main Methods:

• The review synthesizes current knowledge on the ATM-CHK2-p53-p21 and ATR-CHK1-WEE1 pathways.
• It discusses the rationale and ongoing efforts in targeting these pathways for cancer treatment.

Main Results:

• Dysregulation of G1 checkpoint control is a common hallmark of cancer.
• The ATM-CHK2-p53 and ATR-CHK1-WEE1 pathways play critical roles in maintaining genomic integrity by controlling cell cycle progression.
• Targeting these S/G2 checkpoints offers a promising therapeutic avenue.

Conclusions:

• Understanding the intricacies of the ATM-CHK2-p53-p21 and ATR-CHK1-WEE1 pathways is vital for developing effective cancer therapies.
• Targeting these DDR pathways represents a significant area of ongoing research with the potential to improve patient outcomes.